Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Exel Composites’ Annual Financial Report 2018 published

EXEL COMPOSITES PLC     ANNUAL FINANCIAL REPORT    28 FEBRUARY 2019 at 09:00 EETExel Composites has today 28 February 2019 published its Annual Financial Report for 2018. The Annual Financial Report for the period from 1 January to 31 December 2018 includes the Board of Directors’ Report, the review by the President and CEO, the consolidated financial statements, the financial statements of the parent company and the auditor’s report. Exel Composites has today also published a Corporate Governance Statement and a Remuneration Statement for 2018. The above mentioned publications are

Q4 2018 Interim financial report North Investment Group AB (publ)

Highlights  · Robust commercial momentum across all business areas: Strong growth in Norway (20.6%), Sweden somewhat behind 2017 (-4.6%) due to currency effects and public sector delays · Group revenue of SEK 190m during the quarter (+7.1%) and SEK 746m for the year (+1.3%) · EBITDA of SEK 18m in Q4, record-high of SEK 89m in 2018 (+118%, SEK 14m above budget) · Strong order backlog of SEK 103m per Q4 2018 (+19%) · Continued margin improvement as outsourcing strategy takes effect · Acquisition of Sørlie Prosjektinnredninger effective from January 2019 · Rights issue

Recipharm achieves new ISO 45001 certification to support sustainability efforts

Recipharm, the contract development and manufacturing organisation (CDMO), has achieved the new ISO 45001 certification at its Wasserburg facility in Germany. The certification is developed from an earlier certification according to OSHAS 18001 and a result of the Wasserburg facility’s programme to enhance its sustainability and safety efforts. Following an audit in January 2019, the facility, which is one of Recipharm’s sterile manufacturing operations, was recognised for its high calibre occupational health and safety management systems. ISO 45001 is the new working protection

Article about Nexam Chemical in Polymervärlden

The latest issue of the Swedish trade magazine Polymervärlden includes an article about how Nexam Chemical´s products can improve the properties of polymers. Read the article, in Swedish, on the company website www.nexamchemical.com .Note: This news has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version. For further information please contact: Johan Arvidsson, CEO, +46-708 97 44 39,

Itiviti receives 2019 TradingTech Insight Europe Award for Tbricks

Analytics strength of Tbricks highlighted as Itiviti accepts 2019 TradingTech Insight Europe Award. London, UK, February 28, 2019 – Itiviti, the leading global provider of multi-asset trading technology and financial infrastructure, today announced that it has been named a winner of the acclaimed TradingTech Insight (TTI) Europe Awards for 2019. At the awards ceremony held in London yesterday, Itiviti’s Tbricks was recognized as Best Trading Analytics Platform.Presented by A-Team, the TTI Europe Awards have been designed to acknowledge excellence in trading solutions and services for

Notification in accordance with the Finnish Securities Market Act Chapter 9 § 5: BlackRock, Inc.’s holding in Wärtsilä Corporation

Wärtsilä Corporation Stock exchange release, 28 February 2019 at 9 am EETNotification in accordance with the Finnish Securities Market Act Chapter 9 § 5: BlackRock, Inc.’s holding in Wärtsilä CorporationBlackRock, Inc. has informed Wärtsilä Corporation it has crossed above the 5% disclosure limit on shares and voting rights on 26 February 2019. Following the transaction BlackRock, Inc. owns 5.07% of Wärtsilä’s shares and voting rights, while its total holding in Wärtsilä Corporation corresponds to 5.42%.Total position of BlackRock, Inc. and its funds subject to the notification: +----

Polygiene AB (publ.) Interim Report 1 october–31 december 2018

Streamlining operations and a positive year-endQ4 in brief · The operating income increased with 9,2% during the fourth quarter compared to the same period the last year and amounted to MSEK 18.6 (17.1). Year 2018 was amounted to MSEK 69.0 (66.1). · Operating profit/loss (EBIT) for the period, excluding the sales of the Protective Surfaces business area amounted to MSEK 0.5 (0) and for the whole year, to MSEK -2.8 (-6.1). · As part of a streamlining of the business, the Protective business area has been divested, which brought in revenue of MSEK 10.6. · The cash flow of the

Terveystalo Plc: Report by the Board of Directors, Financial Statements and Corporate Governance Statement 2018 published

Terveystalo Plc Annual Financial Report 28 February at 9:00 am EET Terveystalo has published its Annual Report 2018 at https://www.terveystalo.com/en/annual-review-2018/ . The Annual Report 2018 includes the Report by the Board of Directors, Financial Statements, the Statement of Non-Financial Information and the Corporate Governance Statement. The Annual Report is attached to this release as a separate PDF file. Terveystalo Plc For more information, please contact:Kati Kaksonen, Director, Investor Relations and Financial CommunicationsTel. +358 10 345 2034Kati.kaksonen@

Herantis Pharma Plc's Financial Statements Release January 1 - December 31, 2018

Financial Statements ReleaseJanuary 1-December 31, 2018 Progress from safety studies toward clinical proof-of-concept Highlights in January-December 2018: · Herantis Pharma ("Herantis") completed the patient enrolment in the Phase 1 clinical study of Lymfactin in February. · Phase 1-2 clinical study of CDNF expanded in February to the university hospitals of Helsinki and Lund in addition to Stockholm based on a favorable first safety evaluation. · Herantis announced in April positive interim results from its Phase 1 clinical study of Lymfactin® in the treatment of breast

DiviTum provides first biomarker evidence for evaluating palbociclib efficacy in new clinical study presented at AACR

New DiviTum results from a clinical study led by Dr Luca Malorni from the Prato Hospital, Italy will be presented at the American Association of Cancer Research annual meeting, 29 March-3 April, in Atlanta. The study results show that DiviTum can evaluate palbociclib treatment responses in women with breast cancer, supporting the potential of the biomarker as a clinically valuable technology for evaluating the effects of a new, targeted breast cancer therapy.The CDK 4/6 inhibitor, palbociclib, is Pfizer’s successful targeted therapy prescribed to more than 160 000 women with metastatic

Nixu published its 2018 Financial Results - Strong organic growth and preparation for the next steps

Nixu CorporationPress release, February 28, 2019 at 8:35 AM EETEuropean cybersecurity company Nixu has published its financial statements release on February 28, 2019 and the English translation of the release is available on the company’s website at: https://www.nixu.com/release/financial-statements-release-january-1-december-31-2018-ifrs Petri Kairinen, Nixu CEO, commented on the results, “While cybersecurity was frequently in the headlines in 2018 with the emergence of increased transparency of regulation and recurring data breaches, the financial year 2018 was once again a year of

Kongsberg Automotive reports Q4 2018 results

Kongsberg Automotive ASA Q4 2018 Report and Presentation follow attached. Q4 2018 Highlights: · Revenues grew by MEUR 21 (7.3%) YoY to MEUR 288 including negative FX effects of MEUR 1. · We booked new business with MEUR 77 in expected annual revenues corresponding to MEUR 338 in expected lifetime revenues. · Adj. EBIT increased YoY by MEUR 8 to 21 MEUR with no FX effects. · In addition to the fall through from the additional revenues, we also saw improvement in our operations. · Increased costs of raw materials and electronic components continued in Q4 2018 with a YoY

INTERIM REPORT 1 OCTOBER – 31 DECEMBER 2018

INTERIM REPORT OCTOBER – DECEMBER 2018 Fourth quarter of 2018 (October - December) -      Net Turnover of SEK 9 million (SEK -0.8 million) -      Operating Loss/EBIT of SEK -27.4 million (SEK -15 million) -      Result for the period of SEK -30.5 million (SEK -14.6 million) -      Cashflow for the period SEK -43.5 million (SEK -29.5 million) -      Earnings per share amounted to SEK -1.04 (SEK -0.61) -      Production of OXE units: 89 (0) Twelve months to 31stDecember 2018 -      Net Turnover of SEK 40.6 million (SEK 14.6 million) -      Operating Loss/EBIT of

Hunter Group ASA - Q4 report

Financial highlights Net Profit from continuing operations came in at NOK 10.6m in Q4 2018. The net profit in Q4 is mainly attributable to a combination of financial income and advisory fees. Total operating expenses from continuing operations was NOK 4.3m, whereof NOK 0.9m relates to payroll expenses. The NOK 3.4m in other operating expenses consists of NOK 0.7m in general operating expenses and NOK 2.7m in legal fees related to Dwellop-exit etc., which is mainly a reclassification from other equity to other operating expenses in Q4. For further details, please see note 9. Total

EQT Real Estate controls, through Stendörren Real Estate, 40.67 per cent of the shares and 58.14 of the voting rights in Stendörren after the extended acceptance period

On 27 November 2018, EQT Real Estate II[1]  ("EQT Real Estate"), through Stendörren Real Estate AB[2]  ("Stendörren Real Estate"), announced a public cash offer to the shareholders of Stendörren Fastigheter AB (publ) (“Stendörren”) to tender all their shares in Stendörren to Stendörren Real Estate (the "Offer") at a price of SEK 99.69 per share[3]  (the “Offer Price”). On 10 December 2018 Stendörren Real Estate declared the Offer unconditional and that the Offer would be completed. On

CapMan Buyout has sold shares in Harvia Plc

CapMan Buyout press release 28 February 2019 at 8.30 a.m. EET CapMan Buyout has sold shares in Harvia Plc CapMan Buyout X Fund A L.P and CapMan Buyout X Fund B Ky (together the “funds managed by CapMan”) have sold part of their shares in Harvia Plc (”Harvia” or the ”Company”) in an accelerated book-building to a limited number of institutional investors (the ”Share Sale”). The funds managed by CapMan sold a total of 12.3 per cent of the shares and votes in the Company. The subscription price in the Share Sale was set at EUR 6.00 per share and the gross sales proceeds amounted to

Vestas expands 4 MW platform to unlock sites with extreme weather conditions

News release from Vestas Wind Systems A/SAarhus, 28 February 2019 As part of its efforts to offer innovative solutions to meet customer needs, Vestas is introducing the V136-4.2 MW Extreme Climate wind turbine. This new variant of the powerful and proven 4 MW platform offers maximum energy production in low to medium wind speeds, while being designed to handle extreme weather conditions that have previously been challenging to exploit.    The V136-4.2 MW Extreme Climate is being introduced at the 2019 Japan Wind Expo to highlight the turbine’s specific suitability for many project

Otello Corporation announces fourth quarter results

Oslo, Norway - February 28, 2019 - Otello Corporation today reported financial results for the fourth quarter, which ended December 31, 2018. Please find the fourth quarter report (4Q18.pdf) and fourth quarter presentation (4Q18_presentation.pdf) attached. Webcast: https://www.otellocorp.com/ir Petter Lade, CFO Phone: +47 91143878 E-mail: petterl@otellocorp.com About Otello: Otello holds shares in several different businesses, including (i) AdColony which helps publishers monetize their content through advertising and advertisers reach the audiences that build value for their

CapMan issues 5,110,000 new shares in a directed share issue

CapMan Plc Stock Exchange Release28 February 2019 at 8.00 a.m. EET CapMan issues 5,110,000 new shares in a directed share issue CapMan Plc (“CapMan”) executes a directed issue of 5,110,000 new CapMan shares, which correspond to approx. 3 per cent of CapMan’s outstanding shares. The new shares are expected to be registered in the Trade Register on 28 February 2019, as of which date the new shares will establish shareholder rights. The shares are to be traded on the Nasdaq Helsinki Ltd together with the old shares on the day following registration. As a result of the subscriptions,

Solteq Plc Financial Statements Bulletin 1 Jan – 31 Dec 2018 (IFRS)

Solteq Plc Stock Exchange Bulletin 28.2.2019 at 8.00 am The company grew and profitability improved Brief look at January – December 2018 - Revenue totaled 56,867 thousand euros (50,720 thousand euros).- EBITDA was 4,766 thousand euros (2,384 thousand euros). - The adjusted EBITDA was 5,417 thousand euros (4,177 thousand euros).- Operating profit was 2,466 thousand euros (308 thousand euros). - The adjusted operating profit was 3,117 thousand euros (2,101 thousand euros). - Earnings per share was 0,02 euros (-0,08 euros). - Solteq Group’s equity ratio was 32,4 % (33,7 %)

HIDDN: Financial results for the fourth quarter of 2018

Record top line growth, improved EBIT, a significantly reduced negative cash flow and a continued strong cost control, giving improved results and lower operating cost in the fourth quarter of 2018.  (Oslo, 28 February 2019) Hiddn Solutions ASA (Hiddn, OSE: HIDDN) reported revenues of NOK 8.2 million in the fourth quarter of 2018, up from NOK 6.3 million in the corresponding period in 2017, while the negative cash flow from operating activities improved to NOK-3.5 million, down from NOK-11.2 million in the same period in 2017. Hiddn continues to expand the product offering and

Year of integration, enabling pan-European reach

Zalaris achieved full year revenues of NOK 745 million in 2018, up 29 percent year-over-year due to the addition of businesses acquired at the end of 2017 in Continental Europe and the UK. New contracts and renewals signed in the fourth quarter demonstrate a positive change of pace into 2019.Late 2017 Zalaris acquired two companies in Germany and the UK, expanding the company to a pan-European supplier of HR and consulting services. 2018 has been a year of integration, positioning the company for further growth and profitability in 2019. 2018 revenues amounted to NOK 745 million, compared

There are no items matching the current filter
There are no more items matching the current filter
Back to top